Centre for Innovative Biomedicine and Biotechnology
CIBB is a Research Unit of excellence at the University of Coimbra, and an international reference in the domains of Biomedicine and Biotechnology
CIBB is a R&D Unit and an Associate Laboratory which integrates
Q1 Publications | Data from 2018-2023
>2500
Publications
Researchers from
Faculties of Medicine, Pharmacy, Sciences and Economics
Coimbra University Hospital
Key collaborators from biotech and pharma industry
More than 700 members
323 Integrated PhD-holders
222 PhD students
183 Collaborators
Research-oriented Advanced Training
8 PhD Programs
7 MSc Programs
European Training Networks (H2020 MSCA‑ETN)
Highly Internationalized Research
50% of publications as
International Collaborations
Projects
International Projects funded by the European Union, International Foundations and the Private Sector
Clinicians at CIBB
> 50 clinicians
Technology Transfer
23 active IP families
9 Granted IP
11 active Spin-offs
> 20 academia-industry contracts
Selected prizes (2023)
Pfizer Award in basic research
L'Oréal Portugal Medal of Honor for Women in Science
Euretina Award
Several CIBB Researchers have leadership roles in major international scientific societies (eg: European Society for Clinical Investigation - ESCI and European Society for Neurochemistry - ESN) and national scientific societies (eg: Biochemistry, Neuroscience, Pharmacology, Stem Cells & Cell Therapies, Cardiology)
Science Communication
> 4500 News | > 200 M Audiences
> 26 k social networks followers
Public Engagement Activities | > 32 k people reached | > 400 researchers involved | > 25 non-academic collaborations
Data from 2018 - 2023
We use cookies to improve your visit to our website.
